Pregabalin Dosage for Adults
For adults with neuropathic pain, start pregabalin at 150 mg/day (either 50 mg three times daily or 75 mg twice daily), increase to 300 mg/day within 1 week, and use 300 mg/day as the target maintenance dose, as higher doses (600 mg/day) provide no consistent additional benefit but significantly increase adverse effects. 1
Dosing by Indication
Neuropathic Pain (Diabetic Peripheral Neuropathy)
- Starting dose: 50 mg three times daily (150 mg/day)
- Target dose: 100 mg three times daily (300 mg/day) within 1 week
- Maximum dose: 300 mg/day
- Critical caveat: Although 600 mg/day was studied, there is no evidence of additional benefit at this higher dose, and it is less well tolerated with more dose-dependent adverse reactions 1
The Mayo Clinic guidelines confirm this approach, noting that most patients can start at 150 mg/day in 2-3 divided doses, titrate to 300 mg/day after 1-2 weeks, and that 300 mg/day is not consistently more effective than lower doses while carrying greater adverse effect rates 2.
Postherpetic Neuralgia
- Starting dose: 75 mg twice daily OR 50 mg three times daily (150 mg/day)
- Target dose: 300 mg/day within 1 week
- Maximum dose: 600 mg/day (300 mg twice daily OR 200 mg three times daily)
- Important distinction: Reserve doses above 300 mg/day ONLY for patients with ongoing pain who tolerate 300 mg/day but have inadequate relief after 2-4 weeks 1
Seizures (Adjunctive Therapy)
- Starting dose: 150 mg/day
- Maximum dose: 600 mg/day
- Frequency: 2 or 3 divided doses 1
Fibromyalgia
- Starting dose: 75 mg twice daily (150 mg/day)
- Target dose: 300 mg/day within 1 week
- Maximum recommended: 450 mg/day (225 mg twice daily)
- Do not exceed: 450 mg/day—no additional benefit at 600 mg/day 1
Spinal Cord Injury Pain
- Starting dose: 75 mg twice daily (150 mg/day)
- Titration: Increase to 300 mg/day within 1 week
- Maximum dose: 600 mg/day (300 mg twice daily) for patients without adequate relief after 2-3 weeks at 300 mg/day who tolerate the medication 1
Key Titration Principles
Pregabalin has linear pharmacokinetics, making dosing straightforward 2. The drug reaches steady state within 24-48 hours, and efficacy can be observed as early as day 2 in clinical trials 3. This rapid onset allows for faster titration compared to gabapentin, which requires 2+ months for adequate trial 2.
The standard titration schedule:
- Week 1: 150 mg/day
- Week 2: 300 mg/day (maintenance for most patients)
- Week 3+: Consider 600 mg/day ONLY if inadequate response at 300 mg/day AND good tolerability
Special Populations
Renal Impairment
Mandatory dose adjustment because pregabalin is eliminated primarily by renal excretion with <2% metabolism 1, 3. Use the Cockcroft-Gault equation to estimate creatinine clearance, then adjust accordingly:
- CrCl ≥60 mL/min: Standard dosing
- CrCl 30-60 mL/min: Reduce dose by 50%
- CrCl 15-30 mL/min: Reduce dose by 75%
- CrCl <15 mL/min: Further reduction required
- Hemodialysis: Adjust daily dose based on renal function PLUS give supplemental dose after each 4-hour dialysis session 1
Geriatric Patients
Use lower starting doses and slower titration 2. The evidence specifically recommends caution in elderly patients, particularly for trigeminal neuralgia where low-dose pregabalin shows favorable efficacy with minimal adverse effects 4.
Hepatic Impairment
No dose adjustment necessary—pregabalin is not subject to hepatic metabolism and does not induce or inhibit cytochrome P450 enzymes 3.
Critical Safety Considerations
Dose-Dependent Adverse Effects
The most common adverse effects are dizziness, somnolence, peripheral edema, headache, and weight gain 5. These are dose-dependent and can be minimized by:
- Starting at lower doses
- Titrating cautiously
- Avoiding unnecessary escalation above 300 mg/day
Discontinuation
Taper gradually over a minimum of 1 week when discontinuing 1. Abrupt withdrawal can precipitate psychiatric symptoms including anxiety and depression 6.
Abuse Potential
Pregabalin is a Schedule V controlled substance in the United States 2. Recent evidence highlights risks of:
- Psychological dependence, especially in patients with substance use history 4, 6
- Sexual disinhibition in vulnerable populations 6
- Increased lethality when combined with opioids 7
Avoid or use extreme caution in patients with history of substance abuse 4.
Drug Interactions
Pregabalin has minimal drug-drug interactions due to lack of protein binding and hepatic metabolism 3. However, co-prescription with opioids occurs in >25% of cases and significantly increases overdose risk 7.
Common Pitfalls to Avoid
Do not routinely escalate to 600 mg/day—this is the most common prescribing error. The 300 mg/day dose provides optimal benefit-to-risk ratio for most indications 1
Do not use in nerve compression syndromes (e.g., carpal tunnel syndrome) without caution—efficacy is questionable and may delay definitive treatment 4
Do not combine with gabapentin—efficacy of this combination has not been established in controlled trials 1
Do not forget renal dose adjustment—failure to adjust for renal impairment leads to accumulation and increased adverse effects 2, 1
Monitor for misuse indicators in high-risk patients, particularly those on concurrent opioids 7
Administration Details
- Timing: Can be taken with or without food (no clinically relevant effect on absorption) 1, 3
- Frequency: Twice daily or three times daily dosing are equivalent in efficacy 2
- Onset: Efficacy may be apparent as early as week 1 2, 8
- Trial duration: Allow 4 weeks at target dose before declaring treatment failure 2